Join us for a compelling webinar that delves into gastrointestinal pathogen diagnostics and the crucial role of targeted testing options in routine patient care. A Microbiology and Virology Medical ...

Cepheid has received clearance from the US Food and Drug Administration (FDA) for its Xpert GI Panel, a multiplex polymerase chain reaction (PCR) gastrointestinal (GI) pathogen testing solution. The ...

Multiplex molecular diagnostics encompass high‐throughput assays capable of detecting a wide array of gastrointestinal pathogens—bacterial, viral and parasitic—in a single test run. By integrating ...

Gastrointestinal (GI) infections present a formidable challenge to healthcare systems. As we navigate this landscape, we recognize that there are numerous benefits when moving from conventional to ...

The mycobacteria that typically cause lung tuberculosis (TB) can also cause gastrointestinal (GI) TB. This condition typically requires prompt treatment with anti-tuberculous drugs. GI TB can involve ...

Diasorin announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for the LIAISON PLEX Gastrointestinal Flex Assay, a fully customizable syndromic testing panel ...

Traditional methods for gastrointestinal pathogen detection, including immunodiagnostics, culturing, and microscopy, have a long history of successful use. However, they are limited by lengthy ...